Glamyo Health, an asset-light healthcare startup operating in the field of elective surgeries, has announced closing fiscal 2021-22 with an ARR of US $ 8 mn. The brand aims at closing the new fiscal 2022-23 with an ARR US $ 100 mn, the company stated in a press release.

Glamyo Health is a multi-speciality healthcare brand which delivers a hassle-free experience for all types of cosmetic procedures and elective surgeries with personalized care.

The healthcare startup has reached a mark of 400 surgical centers across 26,000 pin codes, adding at least 50-60 centers on an average every quarter. Through aggressive expansion Glamyo Health has been able to penetrate across 16 metropolises in India including – Delhi, Mumbai, Hyderabad, Bangalore, Pune, Chandigarh, Indore, Bhubaneshwar, Patna, Mysore, Madurai, Chennai, Ahmedabad, Nagpur, Lucknow, Kochi, Coimbatore, the release further added.

We have been able to record a month-on-month growth of 25% in terms of revenue. Our aggressive expansion has ensured availability and service. Additionally, we are maintaining a fine customer service and treatments which together have helped us scale rapidly,” said Archit Garg, Co-founder at Glamyo Health.

“We identified the areas where the traditional healthcare system has not served enough. Further, we ensure that we do not just fill the gap, but we fill it with the best in class cutting edge treatment modalities. We shall continue to expand our portfolio of offerings and strive for 100% patient satisfaction. We plan to source some unique technologies from different parts of the world and introduce them in India to bring the industry at par with the global standards,” said Dr. Preet Pal Thakur Co-Founder at Glamyo Health.

In the last year, the brand has already made key global surgical technologies available, including minimally invasive elective and cosmetic surgeries, laser proctology treatments, laparoscopic surgeries, and circumcision.